| Posaconazole SP |
Human |
posaconazole |
posaconazole |
EMEA/H/C/000611 |
Schering-Plough Europe |
2005/10/25
|
Lapsed |
| Xyrem |
Human |
sodium oxybate |
sodium oxybate |
EMEA/H/C/000593 |
UCB Pharma Ltd |
2005/10/13
|
Authorised |
| Ablavar (previously Vasovist) |
Human |
gadofosveset trisodium |
gadofosveset trisodium |
EMEA/H/C/000601 |
TMC Pharma Services Ltd. |
2005/10/03
|
Withdrawn |
| Tarceva |
Human |
erlotinib |
erlotinib |
EMEA/H/C/000618 |
Cheplapharm Registration GmbH |
2005/09/19
|
Authorised |
| Fosavance |
Human |
alendronic acid;colecalciferol |
alendronic acid;colecalciferol |
EMEA/H/C/000619 |
N.V. Organon |
2005/08/24
|
Authorised |
| Aclasta |
Human |
zoledronic acid |
zoledronic acid |
EMEA/H/C/000595 |
Sandoz Pharmaceuticals d.d. |
2005/04/15
|
Authorised |
| Aloxi |
Human |
palonosetron |
palonosetron hydrochloride |
EMEA/H/C/000563 |
Helsinn Birex Pharmaceuticals Ltd. |
2005/03/22
|
Authorised |
| Zonegran |
Human |
zonisamide |
zonisamide |
EMEA/H/C/000577 |
Amdipharm Limited |
2005/03/10
|
Authorised |
| Purevax RCCh |
Veterinary |
vaccine against feline viral rhinotracheitis, feline calicivirosis and feline Chlamydophila infections |
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain);inactivated feline calicivirosis antigens (FCV 431 and G1 strains);attenuated Chlamydophila felis (905 strain) |
EMEA/V/C/000092 |
Merial |
2005/02/22
|
Lapsed |
| Prialt |
Human |
ziconotide |
ziconotide |
EMEA/H/C/000551 |
Esteve Pharmaceuticals GmbH |
2005/02/21
|
Authorised |
| Orfadin |
Human |
nitisinone |
nitisinone |
EMEA/H/C/000555 |
Swedish Orphan Biovitrum International AB |
2005/02/21
|
Authorised |
| Azilect |
Human |
rasagiline |
rasagiline |
EMEA/H/C/000574 |
Teva B.V. |
2005/02/21
|
Authorised |
| Truvada |
Human |
emtricitabine;tenofovir disoproxil |
emtricitabine;tenofovir disoproxil fumarate |
EMEA/H/C/000594 |
Gilead Sciences Ireland UC |
2005/02/20
|
Authorised |
| Quintanrix |
Human |
diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus influenzae type B conjugate vaccine (absorbed) |
Diphtheria toxoid;tetanus toxoid;inactivated Bordetella pertussis;hepatitis B surface antigen (rDNA);Haemophilus influenzae type b polysaccharide |
EMEA/H/C/000556 |
GlaxoSmithKline Biologicals S.A. |
2005/02/17
|
Withdrawn |
| Fendrix |
Human |
hepatitis B (rDNA) vaccine (adjuvanted, adsorbed) |
hepatitis B surface antigen |
EMEA/H/C/000550 |
GlaxoSmithKline Biologicals S.A. |
2005/02/02
|
Authorised |
| Avastin |
Human |
bevacizumab |
bevacizumab |
EMEA/H/C/000582 |
Roche Registration GmbH |
2005/01/12
|
Authorised |
| Cymbalta |
Human |
duloxetine |
duloxetine |
EMEA/H/C/000572 |
Eli Lilly Nederland B.V. |
2004/12/17
|
Authorised |
| Nodetrip (previously Xeristar) |
Human |
duloxetine |
duloxetine |
EMEA/H/C/000573 |
Esteve Pharmaceuticals, S.A. |
2004/12/17
|
Withdrawn |
| Kivexa |
Human |
abacavir;lamivudine |
abacavir;lamivudine |
EMEA/H/C/000581 |
ViiV Healthcare BV |
2004/12/16
|
Authorised |
| Xagrid |
Human |
anagrelide |
anagrelide |
EMEA/H/C/000480 |
Takeda Pharmaceuticals International AG Ireland |
2004/11/15
|
Authorised |